Warning letters, 483s, Recalls, Import Alerts, Audit observations
Warning letter / Centrient India / MARCS-CMS 640196/ 320-23-06/ DECEMBER 07, 2022/ Observation 1 USFDA
Warning letter / Glenmark, Goa, India /FEI 3004672766 / MARCS-CMS 637314/ 320-23-04/ NOVEMBER 22, 2022/
In September 2022, USFDA issued a Warning letter to Lupin API facility at Tarapur, India
USFDA Warning letter to Mylan in 2020 cited inadequacy of cleaning, cleaning procedures, risk assessment of
USFDA Warning letter to Mylan in 2020 cited inadequate procedures to monitor and control recovered
